Clinical trial

An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients

NCT02669563

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-12-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2015-12-01Date precision: month

Registry last updated2017-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiomyopathyunresolved

Interventions

[18F]4F-MHPGDRUG

[18F]3F-PHPGDRUG

[13N]ammoniaDRUG

[11C]HEDDRUG

Sponsors & collaborators

University of Michiganlead sponsor

Mapped research locations

Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02669563 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.